VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
VRPX
Delisted
VRPX was delisted on the 3rd of April, 2025.
18 hedge funds and large institutions have $973K invested in Virpax Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$11.9K | |
| 2 | +$9.09K | |
| 3 | +$7.89K | |
| 4 |
SG
StoneX Group
New York
|
+$7.22K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.44K |
Top Sellers
| 1 | -$120K | |
| 2 | -$41.2K | |
| 3 | -$38.6K | |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$1.24K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$155 |